Evaluation of drug adherence in patients with non-valvular atrial fibrillation according to geographic regions of Turkey: An analysis from NOAC-TR study

Drug adherence to novel oral anticoagulants (NOAC) varied by countries and popuplations. As a result of NOAC-TR study, in Turkey, drug adhrence to NOACs is poor comparing to other real world studies. However it is not known whether there is a difference between geographic regions of Turkey in terms of NOAC adherence. In this study we aim to investigate the NOAC adherence in patients with non-valvular atrial fibrillation according to the geographic regions in Turkey Method: This cros-sectional study was designed as a subgroup study of NOAC-TR (Drug Adherence in patients with non valvular atrial fibrillation taking non-vitamin K antagonist oral anticoagulants in Turkey). A total of 2802 patients (59% female) taking NOAC (Dabigatran, apixaban, rivaroxaban) due to NVAF at least 3 months, were included. Morisky-8 item drug adherence scale was used. Patients were divided in 3 groups (high, moderate and low adherent) based on drug adherence Results: Of the patients 24% were adherent, 26% were moderate adhererent and 50% were low adherent to NOAC treatment. Drug adhrence was different between geographic regions (p

___

1. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-35.

2. Deykin D. Warfarin therapy. N Engl J Med. 1970;283(13):691–694.

3. Shameem R, Ansell J. Disadvantages of VKA and requirements for novel anticoagulants. Best Pract Res Clin Haematol. 2013;26(2):103–14.

4. Connolly S, Ezekowitz M, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2010;361(12):1139–51.

5. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM. Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-91.

6. Granger C, Alexander J, McMurray J, Lopes R, Hylek E, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–92.

7. Schulman S, Kearon C, Kakkar A, Mismetti P, Schellong S, Eriksson H. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361(24):2342–52.

8. Landman G, Gans R. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2011;364(36):2499–510.

9. Blann A, Lip G. Laboratory monitoring of the non-vitamin K oral anticoagulants. J Am Coll Cardiol. 2014;64(11):1140–2.

10. Vrijens B, Heidbuchel H. Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence. Europace. 2015;17(4):514–23.

11. Emren SV, Senöz O, Bilgin M, Beton O, Aslan A, Taşkın U, Açiksari G, Asarcikli LD, Çakır H, Bekar L, Bolat İ, Yayla Ç, Çelebi B, Dalgıç O,Çelik O, Şafak Ö, Akyel S, Güngör H, Düzel B, Zoghi M Drug Adherence in Patients With Nonvalvular Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants in Turkey: NOAC-TR DOI: 10.1177/1076029617693940 | First Published January 1, 2017

12. Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39(4):632-6.

13. Morisky DE, Ang A, Krousel‐Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens. 2008;10(5):348–54.

14. Hacıhasanoğlu Aşılar R, Gözüm S, Çapık C, Morisky DE. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg. 2014;14(8):692-700.

15. Oğuzülken İK, Köktürk N, Işıkdoğan Z, Morisky 8-maddeli ilaca uyum anketinin (MMAS-8) Türkçe geçerliliğinin kanıtlanması çalışması Tuberk Toraks. 2014;62 (2):101-7

16. Schulman S, Shortt B, Robinson M, Eikelboom J. Adherence to anticoagulant treatment with dabigatran in a real-world setting. J Thromb Haemost. 2013;11(7):1295–9.

17. Sherwood MW, Douketis JD, Patel MR, Piccini JP, Hellkamp AS, Lokhnygina Y, Spyropoulos AC, Hankey GJ, Singer DE, Nessel CC. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from ROCKET AF. Circulation. 2014;129(18):1850–9.

18. Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di PG, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS,Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ,Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S. The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study. Circulation. 2013; 128(3):237-43.

19. Yao X, Abraham NS, Alexander GC, Crown W, Montori VM, Sangaralingham LR, Gersh BJ, Shah ND, Noseworthy PA. Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc. 2016;5(2):1-12.

20. McHorney CA, Crivera C, Laliberté F, Nelson WW, Germain G, Bookhart B, Martin S, Schein J, Lefebvre P, Deitelzweig S. Adherence to non-vitaminK-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure. Curr Med Res Opin. 2015;31(12):2167-73.

21. Hanemaaijer S, Sodihardjo F, Horikx A, Wensing M, De Smet PA, Bouvy ML, Teichert M. Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm. 2015;37(6):1128-35.

22. Castellucci LA, Shaw J, van der Salm K, Erkens P, Le Gal G, Petrcich W, Carrier M Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale. Thromb Res. 2015;136(4):727-31.

23. Shen AY, Yao JF, Brar SS, Jorgensen MB, ChenW. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007;50(4):309–15.

24. Fang MC, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation related outcomes among patients taking warfarin. J Gen Intern Med. 2006;21(8):841–6.

25. Orensky IA, Holdford DA. Predictors of noncompliance with warfarin therapy in anoutpatient anticoagulation clinic. Pharmacotherapy. 2005;25(12):1801–8.

26. Johnston JA, Cluxton Jr RJ, Heaton PC, Guo JJ, Moomaw CJ, EckmanMH. Predictors of warfarin use among Ohio medic aid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med. 2003;163(14):1705–10.

27. Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R. Risk factors for nonadherence-to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf. 2008;17(9):853–60.

28. Çelik A, İzci S, Kobat MA, Ateş AH, Çakmak A, Çakıllı Y, Yılmaz MB, Zoghi M; WARFARIN-TR Study Collaborates The wareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARINTR. Anatol J Cardiol. 2016;16(8):595-600.

29. Kılıç S, Çelik A, Çakmak HA, Afşin A, Tekkeşin Aİ, Açıksarı G, Memetoğlu ME, Karadeniz Özpamuk F, Şahan E, Alıcı MH, Dereli Y, Sinan ÜY, Zoghi M. The time in therapeutic range and bleeding complications of warfarin in different geographic regions of Turkey: a subgroup analysis of WARFARINTR Study. Balkan Med J. 10.4274/balkanmedj.2016.1617.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )
Sayıdaki Diğer Makaleler

A comment on “General anesthesia management in carotid endarterectomy surgery: a single center experience”

Ali Sait KAVAKLİ

Atrial fibrillation with Wolff–Parkinson-White syndrome: A case report

Abdulmecit AFŞİN, Kasım TURGUT

The importance of curettage in cases of sexual violence

OSMAN CELBİŞ, TURGAY BÖRK, ABDULLAH KARAER, Ozlem Ozel OZCANLİ, Esra Porgali ZAYMAN

Idiopathic talipes equinovarus with preaxial polydactyly of the foot: a case report

Ali Tufan PEHLİVAN, Süleyman Semih DEDEOĞLU, Yunus İMREN

The evaluation of efficacy of three different ultrasonography methods for verification of gastric tube placement in intensive care unit patients

Funda GÖK

Comparison of hemodynamic response for intubation and propofol pain caused by lidocaine administration with infusion and tourniquet

Mohammed DENİZ, Mustafa Muhlis ALPARSLAN, Koray AK, HATİCE AYSEL ALTAN

Investigation of HBV DNA in HBsAg positive patients

Nihal Seçil BATI, MEHMET SAİT TEKEREKOĞLU, YÜCEL DUMAN

Effect of taping techniques on pain and grip strength in patients with lateral epicondylitis

Khaled Z FOUDA, Ibrahim M DEWİR

Antimicrobial activity and antioxidant potential of the methanolic leaf extracts of three cultivars of date palm trees (Phoenix dactylifera) from Saudi Arabia

Emad Mohamed ABDALLAH, Khalid Hamid MUSA, Kamal Ahmad QURESHİ, Alaa M M SADEEK

A case of hypothermia with significant Osborn Wave: a forgotten electrocardiographic finding

VAHİT DEMİR, Hüseyin EDE, Samet YILMAZ, Şıho HİDAYET, YAŞAR TURAN, Ali Rıza ERBAY